In patients with esophageal squamous-cell carcinoma, anti-TRIM21 Abs have been linked to poor survival, whereas in those with ovarian cancer, a high prevalence of these Abs has been associated with improved OS.24 Here, TRIM21 is linked to ovarian carcinoma.